MedTrace Logo

Treatment of Adolescent Suicide Attempters (TASA)

NCT00080158 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-06-22

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Conditions

Interventions

DRUG

fluoxetine

DRUG

sertraline

DRUG

citalopram

DRUG

escitalopram

DRUG

bupropion

DRUG

mirtazapine

DRUG

venlafaxine

DRUG

lithium

BEHAVIORAL

Cognitive Behavioral Therapy

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Laurence Greenhill, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00080158 on ClinicalTrials.gov